Hormone receptor (HR)+, human epidermal growth factor 2 (HER2)-breast cancer (BC) is the most commonly diagnosed subset of BC, accounting for 60–70% of all cases (1, 2). This evidence concerns the gene ERBB2 and breast carcinoma.